Akari Therapeutics Appoints Biotechnology Industry Leader, Abizer Gaslightwala, as President and Chief Executive OfficerMarch 20, 2025
Akari Therapeutics Announces $7.6 Million Private Placement Offering Led by Existing Shareholders and Insiders Priced at the Market Under Nasdaq RulesMarch 3, 2025
Akari Therapeutics Participates in the Virtual Investor “Top 5 for ‘25” On-Demand ConferenceFebruary 19, 2025
